| Literature DB >> 30704407 |
Suphot Wattanaphansak1, Carlos Eduardo Real Pereira2, Wenika Kaenson1, Pornchalit Assavacheep1, Rachod Tantilertcharoen1, Talita Pilar Resende3, Javier Alberto Barrera-Zarate2, Juliana Saes Vilaça de Oliveira-Lee2, Ulrich Klein4, Connie Jane Gebhart3, Roberto Maurício Carvalho Guedes5.
Abstract
BACKGROUND: Lawsonia intracellularis is an obligate intracellular bacterium which cannot be cultured by conventional bacteriological methods. Furthermore, L. intracellularis needs enriched medium and a unique atmosphere for isolation, cultivation and propagation. Because of this,there are only a few isolates of L. intracellularis available and few studies in vitro demonstrating the susceptibility of this bacterium to antimicrobial agents. The objectives of this study were to isolate South American and Southeast Asia strains of L.intracellularis and to determine the in vitro antimicrobial activity against these isolates. Tested antimicrobials included: chlortetracycline, lincomycin, tiamulin, tylosin and valnemulin(against both Brazilian and Thailand strains) and additionally, amoxicillin, zinc-bacitracin, carbadox, enrofloxacin, gentamicin, sulfamethazine, trimethoprim, spectinomycin and a combination (1:1) of spectinomycin and lincomycin were also tested against the Thai isolates. The minimum inhibitory concentration (MIC) was determined by the antimicrobial activity that inhibited 99% of L. intracellularis growth in a cell culture as compared to the control (antimicrobial-free).Entities:
Keywords: Antimicrobial susceptibility; Ileitis; Lawsonia intracellularis; MIC; Pigs; Proliferative enteropathy
Mesh:
Substances:
Year: 2019 PMID: 30704407 PMCID: PMC6357443 DOI: 10.1186/s12866-019-1397-7
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Extracellular and intracellular MIC endpoints for 5 antimicrobials against two Brazilian L. intracellularis isolates. The bacteria were prepared independently and tested twice. The endpoint was obtained from 3 replicates of each passage. Minimum Inhibitory Concentration (MIC) μg/ml
| Antimicrobials | Minimum Inhibitory Concentration (MIC) μg/ml | |||
|---|---|---|---|---|
| BRPHE01_E5 | BRPHE02_E8 | |||
| Intracellular activity | Extracellular activity | Intracellular activity | Extracellular activity | |
| 1. Chlortetracycline | 32–64 | 32–64 | 8–16 | 64 |
| 2. Lincomycin | > 128 | > 128 | > 128 | > 128 |
| 3. Tiamulin | ≤0.125 | 1–2 | 1–2 | 0.5 |
| 4. Tylosin | 2–8 | > 128 | 2 | 16–32 |
| 5. Valnemulin | ≤0.125 | ≤0.125 | ≤0.125 | ≤0.125 |
Fig. 1An example of an MIC endpoint for tiamulin against L. intracellularis strain CUHE01_SW13 at passage 6. Photographs of McCoy cells infected with L. intracellularis growing in the presence of tiamulin with concentrations ranging from 2 μg/ml to 128 μg/ml. There was no L. intracellularis growth in cells treated with tiamulin at concentrations ranging from 16 μg/ml to 128 μg/ml. The numbers of HICs dramatically increased at the concentration of 4 μg/ml (> 1% compared to control). Therefore, the MIC of tiamulin for this L. intracellularis strain is 8 μg/ml (< 1% compared to control)
Extracellular and intracellular MIC endpoints for 15 antimicrobials against 3 Thailand L. intracellularis isolates. The bacteria were prepared independently and tested twice. The endpoint was obtained from the median value of 3 replicates of each passage
| Antimicrobials | Minimum Inhibitory Concentration (MIC) μg/ml | |||||
|---|---|---|---|---|---|---|
| CUPHE01_SW13 | CUPIA01_SW13 | CUPIA02_SW13 | ||||
| Intracellular activity | Extracellular activity | Intracellular activity | Extracellular activity | Intracellular activity | Extracellular activity | |
| 1. Amoxicillin | 8–16 | > 128 | 8 | > 128 | 16–32 | 64 |
| 2. Carbadox | ≤0.125 | 8 | ≤0.125–0.25 | 0.5–1 | ≤0.125–0.25 | 0.5 |
| 3. Chlortetracycline | > 128–64 | > 128 | > 128 | > 128 | 32 | 32 |
| 4. Colistin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| 5. Enrofloxacin | 8 | > 128 | 4–8 | 64 | 16 | 32–64 |
| 6. Lincomycin | > 128 | > 128 | > 128 | > 128 | > 128 | > 128 |
| 7.Lincomycin+Spectinomycin | 128–64 | 32 | > 128 | 8–4 | 64–128 | 2 |
| 8. Gentamicin | > 128 | > 128 | > 128 | 128- > 128 | > 128 | 64–128 |
| 9. Spectinomycin | 128 | 32 | > 128 | 8–4 | > 128–128 | 4–2 |
| 10. Sulfamethazine | 128 | > 128 | 4–8 | > 128 | 32–64 | > 128 |
| 11. Tiamulin | 1 | 8 | 1 | 4 | ≤0.125–0.25 | 0.5 |
| 12. Trimethoprim | 64 | > 128 | > 128–128 | > 128 | > 128 | > 128 |
| 13. Tylosin | 8–16 | 32 | 4 | 64 | 2 | 8 |
| 14. Valnemulin | ≤0.125 | 0.5–1 | ≤0.125 | 0.5–0.25 | ≤0.125 | 0.25 |
| 15. Zinc-Bacitracin | > 128–128 | > 128 | > 128 | > 128 | > 128 | > 128 |